[PR Newswire] - THOUSAND OAKS, Calif. and TOKYO, May 29, 2013 /PRNewswire/ -- Amgen (NASDAQ:AMGN), the world's largest independent biotechnology company, and Astellas Pharma Inc. (Tokyo Stock Exchange: 4503, "Astellas"), ...
You are receiving this email because you subscribed to this feed at blogtrottr.com.
No comments:
Post a Comment